Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery
about
The Smart Drug Delivery System and Its Clinical PotentialCellular Endocytosis and Trafficking of Cholera Toxin B-Modified Mesoporous Silica NanoparticlesOrganosilica hybrid nanomaterials with a high organic content: syntheses and applications of silsesquioxanes.Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors.Nanobiomaterials' applications in neurodegenerative diseases.Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications.Stealth Biocompatible Si-Based Nanoparticles for Biomedical Applications.Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.Supramolecular chemotherapy based on host-guest molecular recognition: a novel strategy in the battle against cancer with a bright future.Dual-Responsive Mechanized Mesoporous Silica Nanoparticles Based on Sulfonatocalixarene Supramolecular Switches.(19) F NMR Spectroscopy as a Highly Sensitive Method for the Direct Monitoring of Confined Crystallization within Nanoporous Materials.Drug self-assembly for synthesis of highly-loaded antimicrobial drug-silica particles.Subcellular-Scale Drug Transport via Ultrasound-Degradable Mesoporous Nanosilicon to Bypass Cancer Drug Resistance.Enzyme-Controlled Nanodevice for Acetylcholine-Triggered Cargo Delivery Based on Janus Au-Mesoporous Silica Nanoparticles.Design of thermoresponsive polymeric gates with opposite controlled release behaviorsA carbon based drug delivery system derived from a one-dimensional coordination polymer, doxorubicin loading and redox-responsive releaseAu–Mesoporous silica nanoparticles gated with disulfide-linked oligo(ethylene glycol) chains for tunable cargo delivery mediated by an integrated enzymatic control unit
P2860
Q26744837-5394D025-2D31-4055-A06F-4B436A1A7C1BQ28834075-991E981C-379E-41A4-9778-67E2EF331E7AQ39023379-999BDFFA-7EBF-4352-AFE5-D7167BCEF1CEQ39096024-D0DBE54B-2A11-43D8-A458-CE6462187AAEQ39126802-D9083E67-D381-4BB2-9619-6D7A8D36A21AQ39297820-22027BD8-8DC1-4012-AEBF-EEC3DFD6C317Q46048775-99DC576E-09CE-47D6-AA83-299A403CCAEAQ47295411-15DE55E2-D539-4C01-AAAC-CDA207EA728FQ47599299-0684D134-9FB9-41EE-9852-83088876F5A7Q48113588-E82775A1-9737-4EBE-8022-26400FFA34A0Q48210555-851456BF-89A3-416E-AF4F-C989DB309ADCQ48223372-39659E11-53F6-4C0D-ACEF-7BC2E15A7264Q50664203-FAD658D5-4046-46E1-B583-1548FA0EEF46Q53490437-DB762CAF-13C1-4BB9-B61B-D43469534F11Q57367172-097F5DC2-2BA9-4A2F-85FD-B68265624D82Q57377410-767460CE-8C81-4F31-8A78-722F898AFCCEQ57401033-916CCCF4-9BAF-4B74-9399-E8CD1216C477
P2860
Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery
description
im August 2015 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2015
@uk
name
Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery
@en
Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery
@nl
type
label
Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery
@en
Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery
@nl
prefLabel
Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery
@en
Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery
@nl
P2093
P2860
P356
P1476
Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery
@en
P2093
Carole Carcel
Michel Wong Chi Man
Simon Giret
P2860
P304
13850-13865
P356
10.1002/CHEM.201500578
P407
P577
2015-08-06T00:00:00Z